Y-mAbs Therapeutics, Inc. Alternatives & Competitors

12 companies similar to Y-mAbs Therapeutics, Inc. — Innovative pediatric immunotherapies for Real-life Possibilities

Apexigen

Creating Transformative Immunotherapies for Patients with Cancer

11 Post-IPO Equity $175.80M

San Carlos, United States

Biopharma Biotechnology +2

Compare

Antharis Therapeutics, Inc.

Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting...

San Diego, United States

Biopharma Biotechnology +1

iTeos Therapeutics

Cancer Immunotherapies by Design

186 Post-IPO Equity $362.74M

Cambridge, United States

Biotechnology Health Care

Biotecnol Limited

Immunotherapies for Life

London, United Kingdom

Biotechnology Health Care +1

Track all Y-mAbs Therapeutics, Inc. competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Visterra Inc.

We bring better biologics to life. Biospace Best Place to Work 2024!

139 Series C $125.39M

Waltham, United States

Biotechnology Health Care +1

GlobeImmune, Inc.

12 Venture round $128.46M

Louisville, United States

Biotechnology Health and Wellness

Compass Therapeutics Inc.

We are developing next-generation antibodies into transformative cancer therapies that imp...

57 IPO $500.96M

Boston, United States

Biopharma Biotechnology +1

Apollomics

We are a biopharmaceutical company committed to the discovery and development of mono- and...

26 Post-IPO Equity $262.60M

Foster City, United State...

Biotechnology Health Care +1

Targazyme

11 Series A $60.00M

Biopharma Biotechnology +2

OncXerna Therapeutics

Advancing a new paradigm of precision oncology with a RNA-based approach to match patients...

8 Venture round $126.50M

Waltham, United States

Biopharma Biotechnology +3

Compare

Lumos Pharma

Transforming Lives with Rare Focus

47 Series B $53.50M

Austin, United States

Biopharma Biotechnology +2

Innolake Biopharm

A clinical stage biotech company, aiming to provide innovative therapeutics in oncology an...

5 Series A $400.00M

Shanghai, China

Biotechnology Health and Wellness

About Y-mAbs Therapeutics, Inc.

Y-mAbs Therapeutics, Inc. is a commercial-stage clinical biopharmaceutical company founded in 2015, headquartered in the United States. The company is dedicated to developing and commercializing innovative pediatric immunotherapies for the treatment of cancer.

Taxonomy

Pediatric Immunotherapies, Oncology Products, Antibody-based Therapeutics, Clinical Biopharmaceutical Company, Cancer Treatment, Medical Needs, Pivotal-stage Product Candidates, Commercial-stage, Innovative Therapies, Biopharmaceutical, Medical Research, Collaborations, Partnerships, Cancer Care, Patient Outcomes

Frequently Asked Questions

Companies similar to Y-mAbs Therapeutics, Inc. include Apexigen, Antharis Therapeutics, Inc., iTeos Therapeutics, Biotecnol Limited, Visterra Inc.. They work in Biotechnology and Health Care and share Y-mAbs Therapeutics, Inc.'s focus on cancer treatment, biopharmaceutical and antibody-based therapeutics.

Bounce Watch lists 12 companies that share Y-mAbs Therapeutics, Inc.'s industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Y-mAbs Therapeutics, Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Y-mAbs Therapeutics, Inc. Profile Apexigen Alternatives Antharis Therapeutics, Inc. Alternatives iTeos Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Y-mAbs Therapeutics, Inc. on 9 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.